반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/ 임상시험 |
Emerging Market Quarterly Mergers, Acquisitions, and Financing– Q1 2023 | 03-29-2023 |
| Emerging Markets Contract Service Agreements– Q1 2023 | 03-29-2023 | |
| Clinical Trials: A Scorecard for Clinical Trial Investigations in 2022 | 03-28-2023 | |
| Comparison of Humira Biosimilars in the US and Europe | 03-24-2023 | |
| Novel FDA Drug Approvals Massively Declined in 2022 but What Are the Opportunities for CMOs in 2023? | 03-24-2023 | |
| Alzheimer's Drug Leqembi Set to Generate $12.9 Billion in Sales by 2028 | 03-24-2023 | |
| Biotech’s Post-IPO Boom: Rebounding from a 2022 Low? | 03-23-2023 | |
| Prometheus’ PRA023 Could Address an Immediate Need in Crohn’s Disease Treatment | 03-23-2023 | |
| AbbVie Parkinson’s Drug ABBV-951 Faces a Few Hurdles Before FDA Approval | 03-23-2023 | |
| Race for a First-to-Market Therapy for NASH Heats Up | 03-20-2023 | |
| Pfizer Acquires ADC Pioneer Seagen for $43 Billion to Expand Oncology Portfolio | 03-20-2023 | |
| 질환별 | Obesity: Seven-Market Drug Forecast and Market Analysis | 03-28-2023 |
| Chronic Kidney Disease: 68-Market Analysis and Sales Forecast | 03-28-2023 | |
| Shaping AML Treatment: How Menin Inhibitors Are Changing the Game | 03-20-2023 | |

반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| [국가임상시험지원재단] 해외 임상시험 정보 데이터(Global Data) 보고서 (0) | 2023.11.29 |
|---|---|
| <Vendor 기업 주력 사업 조사> (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |